A Study of Suzetrigine (SUZ) Spray-dried Dispersion (SSD) in Healthy Adult Panelists

Last updated: May 9, 2025
Sponsor: Vertex Pharmaceuticals Incorporated
Overall Status: Completed

Phase

1

Condition

Pain

Treatment

SUZ

Clinical Study ID

NCT06834009
VX24-548-020
  • Ages 25-80
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The purpose of this study is to evaluate the sensory attributes (basic tastes, aroma, texture, mouthfeel) of SUZ SDD and assess the impact of the dose on the sensory attributes.

Eligibility Criteria

Inclusion

Key Inclusion Criteria:

  • Panelists are qualified based on training and experience. They will be required todetect, identify, recognize, and accurately describe different taste elements andflavor combinations.

Exclusion

Key Exclusion Criteria:

  • History of any illness or clinical condition that, in the opinion of theinvestigator, might confound the results of the study or pose an additional risk tothe participant

  • Sensitivity to SUZ

  • Pregnant, nursing, or planning to become pregnant during the study

Other protocol defined Inclusion/Exclusion criteria may apply.

Study Design

Total Participants: 10
Treatment Group(s): 1
Primary Treatment: SUZ
Phase: 1
Study Start date:
March 10, 2025
Estimated Completion Date:
April 24, 2025

Study Description

This clinical trial information was submitted voluntarily under the applicable law and, therefore, certain submission deadlines may not apply. (That is, clinical trial information for this applicable clinical trial was submitted under section 402(j)(4) (A) of the Public Health Service Act and 42 CFR 11.60 and is not subject to the deadlines established by sections 402(j)(2) and (3) of the Public Health Service Act or 42 CFR 11.24 and 11.44.).

Connect with a study center

  • Senopsys, LLC

    Woburn, Massachusetts 01801
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.